Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Mondelez International
MDLZ
$77.1B
| $931M | 0.32% |
22,627,891
+1,938,216
| +9% | +$76M |
2013 Q2
8 quarters
|
|
52
Accenture
ACN
$128B
| $920M | 0.32% |
9,504,697
+101,787
| +1% | +$9.73M |
2013 Q2
8 quarters
|
|
|
AGN
53
DELISTED
Allergan plc
AGN
| $909M | 0.32% |
2,995,257
-38,019
| -1% | -$11.3M |
2013 Q2
8 quarters
|
|
54
iShares MSCI Japan ETF
EWJ
$23.9B
| $904M | 0.31% |
17,639,298
+8,747,787
| +98% | +$456M |
2013 Q2
8 quarters
|
|
55
Berkshire Hathaway Class B
BRK.B
$1.1T
| $900M | 0.31% |
6,611,393
-71,609
| -1% | -$10.2M |
2013 Q2
8 quarters
|
|
|
56
Home Depot
HD
$290B
| $897M | 0.31% |
8,067,142
-2,296,656
| -22% | -$257M |
2013 Q2
8 quarters
|
|
57
iShares US Real Estate ETF
IYR
$4.16B
| $895M | 0.31% |
12,553,375
+7,825,615
| +166% | +$593M |
2013 Q2
8 quarters
|
|
|
MJN
58
DELISTED
Mead Johnson Nutrition Company
MJN
| $890M | 0.31% |
9,867,418
-187,415
| -2% | -$18.1M |
2013 Q2
8 quarters
|
|
59
Zoetis
ZTS
$30.9B
| $889M | 0.31% |
18,436,813
+5,477,212
| +42% | +$261M |
2013 Q2
8 quarters
|
|
60
Bristol-Myers Squibb
BMY
$121B
| $876M | 0.3% |
13,166,428
-852,663
| -6% | -$56.2M |
2013 Q2
8 quarters
|
|
61
Honeywell
HON
$65.8B
| $852M | 0.3% |
9,296,677
+222,564
| +2% | +$20.8M |
2013 Q2
8 quarters
|
|
62
Intuitive Surgical
ISRG
$150B
| $848M | 0.29% |
15,754,536
-2,095,749
| -12% | -$117M |
2013 Q2
8 quarters
|
|
63
Prudential Financial
PRU
$39B
| $841M | 0.29% |
9,611,199
+1,857,231
| +24% | +$158M |
2013 Q2
8 quarters
|
|
64
Vornado Realty Trust
VNO
$6.28B
| $825M | 0.29% |
10,756,775
+1,098,639
| +11% | +$91.1M |
2013 Q2
8 quarters
|
|
65
Gilead Sciences
GILD
$187B
| $825M | 0.29% |
7,046,962
-885,322
| -11% | -$96.7M |
2013 Q2
8 quarters
|
|
66
Nike
NKE
$51.6B
| $820M | 0.28% |
15,184,916
-45,138
| -0.3% | -$2.31M |
2013 Q2
8 quarters
|
|
67
iShares Russell 1000 Growth ETF
IWF
$130B
| $799M | 0.28% |
32,286,480
+1,023,440
| +3% | +$25.7M |
2013 Q2
8 quarters
|
|
68
Bank of America
BAC
$380B
| $785M | 0.27% |
46,103,365
-3,508,497
| -7% | -$57.8M |
2013 Q2
8 quarters
|
|
69
Abbott
ABT
$172B
| $781M | 0.27% |
15,916,804
+185,701
| +1% | +$8.92M |
2013 Q2
8 quarters
|
|
|
WBA
70
DELISTED
Walgreens Boots Alliance
WBA
| $777M | 0.27% |
9,199,611
+1,648,514
| +22% | +$142M |
2013 Q2
8 quarters
|
|
71
TSMC
TSM
$2.35T
| $773M | 0.27% |
34,053,647
-35,857
| -0.1% | -$856K |
2013 Q2
8 quarters
|
|
72
American Express
AXP
$208B
| $762M | 0.26% |
9,801,513
+836,094
| +9% | +$66.3M |
2013 Q2
8 quarters
|
|
|
MHFI
73
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $761M | 0.26% |
7,577,227
-935,699
| -11% | -$97.8M |
2013 Q2
8 quarters
|
|
74
IBM
IBM
$214B
| $757M | 0.26% |
4,865,942
+1,027,189
| +27% | +$165M |
2013 Q2
8 quarters
|
|
75
State Street Consumer Staples Select Sector SPDR ETF
XLP
$13.7B
| $741M | 0.26% |
15,569,791
+8,748,346
| +128% | +$427M |
2013 Q2
8 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.